Status:
TERMINATED
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This study is being done to find out the good and bad effects of a drug that is not approved for sale and the effects if any on measures of pulmonary function in adult males and females with type 1 di...
Detailed Description
Pfizer announced in October 2007 that it would stop marketing Exubera. Nektar, the company from which Pfizer licensed Exubera, announced on April 9, 2008 that it had stopped its search for a new marke...
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus
Exclusion
- severe asthma or COPD
- smoking
- brittle diabetes
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
582 Patients enrolled
Trial Details
Trial ID
NCT00137046
Start Date
May 1 2002
End Date
December 1 2008
Last Update
February 18 2010
Active Locations (73)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Fullerton, California, United States, 92835
2
Pfizer Investigational Site
Long Beach, California, United States, 90806
3
Pfizer Investigational Site
Sacramento, California, United States, 95816
4
Pfizer Investigational Site
San Diego, California, United States, 92103